MHC Class II and allergen-specific T cell clones

Authors

  • Robyn E. O'Hehir,

    1. ImmuLogic Pharmaceutical Corporation, 855 California Avenue, Palo Alto, CA 94304, U.S.A. and Department of Immunology, Wright-Fleming Institute, St. Mary's Hospital Medical School, London W2 1PG, U.K.
    Search for more papers by this author
  • Jonathan R. Lamb

    1. ImmuLogic Pharmaceutical Corporation, 855 California Avenue, Palo Alto, CA 94304, U.S.A. and Department of Immunology, Wright-Fleming Institute, St. Mary's Hospital Medical School, London W2 1PG, U.K.
    Search for more papers by this author

Ancillary